EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma

Zhaoxuan Wang iD, Weijiao Xu, Lei Zhao, Lin Zhong, Wendan Yu, Shengmin Wang, Lu Sun, Tao Guo, Fengzhou Li, Zhuoshi Li, Lei Fang, Shiqing Wang und 5 weitere

Advanced Science · 2026-03 · 13 (13)

DOI: 10.1002/advs.202513606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.12.2025. Verfasst von Zhaoxuan Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Ferroptosis, Receptors, Aryl Hydrocarbon, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Dalian Science and Technology Innovation Fund, Dalian Key Medical Specialty Dengfeng Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) displays marked intratumoral heterogeneity with distinct histological patterns. The solid pattern representing poorly differentiated LUAD is linked to poor prognosis and therapeutic resistance. To uncover underlying mechanisms, we integrate bulk and single‐cell RNA sequencing and identify a preferential enrichment of interleukin 4 induced 1 (IL4I1)‐expressing tumor‐associated macrophages (TAMs) and tryptophan 2,3‐dioxygenase (TDO2)‐expressing myofibroblastic cancer‐associated fibroblasts (myCAFs) in a solid pattern of LUAD. Spatial transcriptomics reveals their co‐localization in peritumoral stroma, forming an immune‐excluded niche. Mechanistically, TDO2⁺ myCAFs promoted monocyte‐to‐IL4I1⁺ TAM differentiation via the kynurenine‐aryl hydrocarbon receptor (AhR) axis. Tryptophan metabolomic landscapes confirm that IL4I1⁺ TAMs and TDO2⁺ myCAFs enhance tryptophan degradation and accumulation of AhR ligands (e.g., kynurenine, indole‐3‐carboxaldehyde), contributing to CD8⁺ T cell exhaustion and anti‐PD‐1 therapeutic resistance. IL4I1⁺ TAMs and TDO2⁺ myCAFs conformably mediate ferroptosis resistance through the AhR‐NRF2‐GPX4‐SLC7A11 pathway. Notably, AhR antagonist CH‐223191 restores ferroptosis sensitivity of tumor cells. A triple therapy combining CH‐223191, ferroptosis inducer (Imidazole ketone erastin or RSL3), and anti‐PD‐1 agent demonstrates superior efficacy and safety in vivo. Together, our findings demonstrate that IL4I1⁺ TAMs and TDO2⁺ myCAFs synergistically establish an immunosuppressive, ferroptosis‐resistant niche via AhR signaling in solid predominant LUAD and offer promising therapeutic strategies to reprogram the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisReceptors, Aryl HydrocarbonAdenocarcinoma of LungLung NeoplasmsTryptophan OxygenaseMacrophagesHumansAnimalsMiceTumor-Associated MacrophagesTumor MicroenvironmentCancer-Associated FibroblastsCell Line, TumorImmune ToleranceBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

cancer‐associated fibroblastsferroptosishistological subtypeslung adenocarcinomatumor microenvironmenttumor‐associated macrophages

Substanzen

Receptors, Aryl HydrocarbonTryptophan OxygenaseAHR protein, humanBasic Helix-Loop-Helix Proteins

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Thoracic Tumor Biotherapy, Shanghai, China.
  • Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
  • Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, China.

ORCID-Profile: Zhaoxuan Wang

Förderung

  • National Natural Science Foundation of China
  • Dalian Science and Technology Innovation Fund
  • Dalian Key Medical Specialty Dengfeng Project

Zitieren

APA

Wang, Z., Xu, W., Zhao, L., Zhong, L., Yu, W., Wang, S., Sun, L., Guo, T., Li, F., Li, Z., Fang, L., Wang, S., Zhang, G., Xue, G., Guo, W., Zhao, S., & Gu, C. (2026). IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma. Advanced Science, 13(13). https://doi.org/10.1002/advs.202513606

Vancouver

Wang Z, Xu W, Zhao L, Zhong L, Yu W, Wang S, et al. IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma. Advanced Science. 2026;13(13). doi:10.1002/advs.202513606

BibTeX
@article{Wang2026,
  author = {Wang, Zhaoxuan and Xu, Weijiao and Zhao, Lei and Zhong, Lin and Yu, Wendan and Wang, Shengmin and Sun, Lu and Guo, Tao and Li, Fengzhou and Li, Zhuoshi and Fang, Lei and Wang, Shiqing and Zhang, Guohui and Xue, Guoqing and Guo, Wei and Zhao, Shilei and Gu, Chundong},
  title = {IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {13},
  doi = {10.1002/advs.202513606}
}
Kostenlos starten →